510(k) K262971
K262971 is an FDA 510(k) premarket notification submitted by Cepheid for the device "Xpert® Hemorrhagic Fever Panel". The FDA issued a decision of Substantially Equivalent on Oct 30, 2026. The device falls under product code QVR (Multiplex Nucleic Acid Detection System For Biothreat Agents), a Class II device regulated under 21 CFR 866.4000. Cepheid has 52 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 30, 2026
- Date Received
- Aug 26, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Multiplex Nucleic Acid Detection System For Biothreat Agents
- Device Class
- Class II
- Regulation Number
- 866.4000
- Review Panel
- MI
- Submission Type
- 510(k)
A multiplex nucleic acid detection system for biothreat agents is a qualitative in vitro diagnostic test for detection and identification of nucleic acids from biothreat pathogens in human clinical specimens